The government recently began its nationwide Covid-19 vaccination drive wherein around 191,000 healthcare and frontline workers got inoculated.
Following an adverse event during the phase I clinical trial which was immediately reported to the CDSCO-DCGI, Bharat Biotech has finally entered
Biocon’s subsidiary Syngene claims it has manufactured better testing technology for COVID-19 pandemic. The company is likely to bring the
Recently, the Indian Council of Medical Research (ICMR) declared that likely anti-viral agents including Remdesivir,